(Q31063014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

title

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Hovagim Bakardjian

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Sebastian J Crutch

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Giovanni B. Frisoni

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

José Luis Molinuevo

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Sid O'Bryant

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Enrica Cavedo

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Enrica Cavedo

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

23

Miia Kivipelto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

22

David M Holtzman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

4

Philip Scheltens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Jean-François Dartigues

14

object named as

Jean-François Dartigues

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

28

Christopher Rowe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

30

Lon S Schneider

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

5

Paul Aisen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

31

Reisa Sperling

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

10

Kaj Blennow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

27

Gil D Rabinovici

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

33

Maria C Carrillo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

34

Jeffrey Cummings

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

32

Marc Teichmann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

29

Stephen Salloway

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

6

Sandrine Andrieu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

11

Karl Broich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

2

Harald Hampel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

21

Marie-Odile Habert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

15

Charles Duyckaerts

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

18

Serge Gauthier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

Habib Benali

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Lars Bertram

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Stéphane Epelbaum

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Remy Genthon

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Alida A Gouw

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Simone Lista

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Cliff R Jack

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Bruno Dubois

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Enrica Cavedo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

publication date

1 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

published in

Alzheimer's and Dementia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

page(s)

292-323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

31 March 2020

cites work

1 reference

12 December 2020

Influence of leisure activity on the incidence of Alzheimer's Disease

1 reference

12 December 2020

The clinical phenotype of familial and sporadic late onset Alzheimer's disease.

1 reference

12 December 2020

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

1 reference

12 December 2020

[Familial forms of Alzheimer's disease]

1 reference

12 December 2020

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI

1 reference

12 December 2020

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

1 reference

12 December 2020

A meta-analytic review of verbal fluency deficits in depression

1 reference

12 December 2020

Alzheimer's disease: identical phenotype of familial and non-familial cases

1 reference

12 December 2020

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

1 reference

12 December 2020

Brain reserve and dementia: a systematic review

1 reference

12 December 2020

The P300 component in patients with Alzheimer's disease and their biological children

1 reference

12 December 2020

The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.

1 reference

12 December 2020

Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's disease.

1 reference

12 December 2020

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.

1 reference

12 December 2020

Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women

1 reference

12 December 2020

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

1 reference

12 December 2020

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

1 reference

12 December 2020

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

1 reference

12 December 2020

Brain structural alterations before mild cognitive impairment.

1 reference

12 December 2020

Neuropathological stageing of Alzheimer-related changes

1 reference

12 December 2020

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

1 reference

12 December 2020

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

1 reference

12 December 2020

Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study

1 reference

12 December 2020

Selective changes of resting-state networks in individuals at risk for Alzheimer's disease

1 reference

12 December 2020

1 reference

12 December 2020

Prefrontal cortex atrophy predicts dementia over a six-year period

1 reference

12 December 2020

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study

1 reference

12 December 2020

Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study

1 reference

12 December 2020

APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway

1 reference

12 December 2020

Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment

1 reference

12 December 2020

Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal

1 reference

12 December 2020

A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics.

1 reference

12 December 2020

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

1 reference

12 December 2020

Prodromal Alzheimer's disease: successive emergence of the clinical symptoms

1 reference

12 December 2020

Elderly women with larger social networks are less likely to develop dementia

1 reference

12 December 2020

Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease

1 reference

12 December 2020

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers

1 reference

12 December 2020

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

1 reference

12 December 2020

Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease

1 reference

12 December 2020

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

1 reference

12 December 2020

Neurodegenerative diseases target large-scale human brain networks

1 reference

12 December 2020

Age, neuropathology, and dementia.

1 reference

12 December 2020

Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment

1 reference

12 December 2020

Amyloid + activation = Alzheimer's?

1 reference

12 December 2020

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

1 reference

12 December 2020

Approaching clinical proteomics: current state and future fields of application in cellular proteomics

1 reference

12 December 2020

Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress

1 reference

12 December 2020

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

1 reference

12 December 2020

Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer's disease and at-risk older individuals

1 reference

12 December 2020

Total and phosphorylated tau protein as biological markers of Alzheimer's disease

1 reference

12 December 2020

Cortical event-related potentials in preclinical familial Alzheimer disease

1 reference

12 December 2020

Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition

1 reference

12 December 2020

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

1 reference

12 December 2020

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

12 December 2020

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

12 December 2020

Are subjective cognitive complaints a risk factor for dementia?

1 reference

12 December 2020

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

1 reference

12 December 2020

Effect of Alzheimer disease genetic risk disclosure on dietary supplement use

1 reference

12 December 2020

Relationship between atrophy and beta-amyloid deposition in Alzheimer disease

1 reference

12 December 2020

Cognition, reserve, and amyloid deposition in normal aging

1 reference

12 December 2020

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans

1 reference

12 December 2020

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

1 reference

12 December 2020

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

1 reference

12 December 2020

Instrumental activities of daily living among community-dwelling older adults: discrepancies between self-report and performance are mediated by cognitive reserve.

1 reference

12 December 2020

Visual short-term memory binding deficits in familial Alzheimer's disease.

1 reference

12 December 2020

Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease

1 reference

12 December 2020

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

1 reference

12 December 2020

Exercise and Alzheimer's disease biomarkers in cognitively normal older adults

1 reference

12 December 2020

MEG connectivity analysis in patients with Alzheimer's disease using cross mutual information and spectral coherence.

1 reference

12 December 2020

A serum protein-based algorithm for the detection of Alzheimer disease

1 reference

12 December 2020

Functional connectivity in mild cognitive impairment during a memory task: implications for the disconnection hypothesis.

1 reference

12 December 2020

Selective disruption of the cerebral neocortex in Alzheimer's disease

1 reference

12 December 2020

Revising the definition of Alzheimer's disease: a new lexicon.

1 reference

12 December 2020

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop

1 reference

12 December 2020

The genetics of Alzheimer disease: back to the future

1 reference

12 December 2020

Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease

1 reference

12 December 2020

Biomarkers for Alzheimer's disease therapeutic trials

1 reference

12 December 2020

The pathological process underlying Alzheimer's disease in individuals under thirty

1 reference

12 December 2020

Cerebrospinal fluid biomarkers in Alzheimer's disease families with PSEN1 mutations.

1 reference

12 December 2020

Tau pathology in children and young adults: can you still be unconditionally baptist?

1 reference

12 December 2020

Multimodal classification of Alzheimer's disease and mild cognitive impairment

1 reference

12 December 2020

Mapping out biomarkers for Alzheimer disease.

1 reference

12 December 2020

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

1 reference

12 December 2020

Exercise training increases size of hippocampus and improves memory

1 reference

12 December 2020

Tau and p-tau as CSF biomarkers in dementia: a meta-analysis

1 reference

12 December 2020

The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease

1 reference

12 December 2020

1 reference

12 December 2020

Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition

1 reference

12 December 2020

Preclinical AD Workgroup staging: pathological correlates and potential challenges.

1 reference

12 December 2020

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

12 December 2020

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

12 December 2020

Cognitively preserved subjects with transitional cerebrospinal fluid ß-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas.

1 reference

12 December 2020

Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies

1 reference

12 December 2020

Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study

1 reference

12 December 2020

The relative efficiency of time-to-threshold and rate of change in longitudinal data

1 reference

12 December 2020

Presymptomatic apolipoprotein E genotyping for Alzheimer's disease risk assessment and prevention

1 reference

12 December 2020

Influences of APOE ε4 and expertise on performance of older pilots

1 reference

12 December 2020

Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia

1 reference

12 December 2020

1 reference

12 December 2020

Evidence for ordering of Alzheimer disease biomarkers

1 reference

12 December 2020

Cerebrospinal fluid biomarkers, education, brain volume, and future cognition

1 reference

12 December 2020

Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease

1 reference

12 December 2020

Prevention trials in Alzheimer's disease: an EU-US task force report.

1 reference

12 December 2020

Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements

1 reference

12 December 2020

Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments

1 reference

12 December 2020

The role of genetics for biomarker development in neurodegeneration

1 reference

12 December 2020

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

1 reference

12 December 2020

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

1 reference

12 December 2020

A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI

1 reference

12 December 2020

Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature

1 reference

12 December 2020

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

1 reference

12 December 2020

Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition

1 reference

12 December 2020

Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.

1 reference

12 December 2020

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

1 reference

12 December 2020

Association of lifetime cognitive engagement and low β-amyloid deposition

1 reference

12 December 2020

1 reference

12 December 2020

The genetics of Alzheimer's disease

1 reference

12 December 2020

Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology

1 reference

12 December 2020

Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease

1 reference

12 December 2020

Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer's disease.

1 reference

12 December 2020

Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults.

1 reference

12 December 2020

Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot

1 reference

12 December 2020

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

1 reference

12 December 2020

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

1 reference

12 December 2020

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

1 reference

12 December 2020

Blood-based protein biomarkers for diagnosis of Alzheimer disease.

1 reference

12 December 2020

Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI).

1 reference

12 December 2020

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

1 reference

12 December 2020

What is a certified reference material?

1 reference

12 December 2020

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

1 reference

12 December 2020

Subjective cognitive complaints and amyloid burden in cognitively normal older individuals

1 reference

12 December 2020

Fluid biomarkers in Alzheimer disease

1 reference

12 December 2020

Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial

1 reference

12 December 2020

Indicators of amyloid burden in a population-based study of cognitively normal elderly

1 reference

12 December 2020

Alzheimer disease: from inherited to sporadic AD-crossing the biomarker bridge.

1 reference

12 December 2020

Injury markers predict time to dementia in subjects with MCI and amyloid pathology

1 reference

12 December 2020

Cognitive reserve in ageing and Alzheimer's disease.

1 reference

12 December 2020

Enrichment and stratification for predementia Alzheimer disease clinical trials

1 reference

12 December 2020

Potential sources of interference on Abeta immunoassays in biological samples

1 reference

12 December 2020

Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals

1 reference

12 December 2020

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

1 reference

12 December 2020

Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment

1 reference

12 December 2020

Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints

1 reference

12 December 2020

Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

1 reference

12 December 2020

Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers Consortium

1 reference

12 December 2020

Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement.

1 reference

12 December 2020

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

1 reference

12 December 2020

A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease.

1 reference

12 December 2020

Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.

1 reference

12 December 2020

[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

1 reference

12 December 2020

Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease

1 reference

12 December 2020

A quantitative histological study of early clinical and preclinical Alzheimer's disease.

1 reference

12 December 2020

Screening for predementia AD: time-dependent operating characteristics of episodic memory tests

1 reference

12 December 2020

The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly

1 reference

12 December 2020

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

1 reference

12 December 2020

Regulatory innovation and drug development for early-stage Alzheimer's disease

1 reference

12 December 2020

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

1 reference

12 December 2020

Meta-analysis of amyloid-cognition relations in cognitively normal older adults

1 reference

12 December 2020

Effect of cognitive reserve markers on Alzheimer pathologic progression

1 reference

12 December 2020

Diagnosis and management of Alzheimer's disease: past, present and future ethical issues

1 reference

12 December 2020

Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden

1 reference

12 December 2020

CSF biomarker variability in the Alzheimer's Association quality control program

1 reference

12 December 2020

A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study

1 reference

12 December 2020

Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease

1 reference

12 December 2020

Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.

1 reference

12 December 2020

Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid

1 reference

12 December 2020

Multiplex biomarkers in blood.

1 reference

12 December 2020

Fluid biomarkers in Alzheimer's disease - current concepts

1 reference

12 December 2020

Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force

1 reference

12 December 2020

CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease

1 reference

12 December 2020

The future of blood-based biomarkers for Alzheimer's disease

1 reference

12 December 2020

Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease

1 reference

12 December 2020

A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II.

1 reference

12 December 2020

Altered oscillation and synchronization of default-mode network activity in mild Alzheimer's disease compared to mild cognitive impairment: an electrophysiological study

1 reference

12 December 2020

Seeded strain-like transmission of β-amyloid morphotypes in APP transgenic mice

1 reference

12 December 2020

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

1 reference

12 December 2020

Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers

1 reference

12 December 2020

Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.

1 reference

12 December 2020

Early indications of future cognitive decline: stable versus declining controls

1 reference

12 December 2020

Alzheimer disease: from biomarkers to diagnosis

1 reference

12 December 2020

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls

1 reference

12 December 2020

Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial

1 reference

12 December 2020

Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study

1 reference

12 December 2020

Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

1 reference

12 December 2020

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

1 reference

12 December 2020

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease

1 reference

12 December 2020

CSF biomarkers of Alzheimer disease: "noncognitive" outcomes

1 reference

12 December 2020

Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review

1 reference

12 December 2020

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.

1 reference

12 December 2020

Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects

1 reference

12 December 2020

Biomarker modeling of Alzheimer's disease

1 reference

12 December 2020

Developing novel blood-based biomarkers for Alzheimer's disease

1 reference

12 December 2020

CSF Apo-E levels associate with cognitive decline and MRI changes

1 reference

12 December 2020

Future directions in Alzheimer's disease from risk factors to prevention

1 reference

12 December 2020

Compensatory mechanisms in higher-educated subjects with Alzheimer’s disease: a study of 20 years of cognitive decline

1 reference

12 December 2020

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease

1 reference

12 December 2020

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition

1 reference

12 December 2020

Advances in the prevention of Alzheimer's disease and dementia

1 reference

12 December 2020

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

1 reference

12 December 2020

Plasma phospholipids identify antecedent memory impairment in older adults.

1 reference

12 December 2020

Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers

1 reference

12 December 2020

The A4 study: stopping AD before symptoms begin?

1 reference

12 December 2020

Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults

1 reference

12 December 2020

Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.

1 reference

12 December 2020

Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort.

1 reference

12 December 2020

Aerobic exercise increases hippocampal volume in older women with probable mild cognitive impairment: a 6-month randomised controlled trial

1 reference

12 December 2020

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

1 reference

12 December 2020

Medial temporal atrophy in early and late-onset Alzheimer's disease

1 reference

12 December 2020

Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease

1 reference

12 December 2020

An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease

1 reference

12 December 2020

Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology.

1 reference

12 December 2020

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

1 reference

12 December 2020

Apolipoprotein E in Alzheimer's disease: an update

1 reference

12 December 2020

Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.

1 reference

12 December 2020

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

1 reference

12 December 2020

Secondary prevention trials in Alzheimer disease: the challenge of identifying a meaningful end point

1 reference

12 December 2020

The preclinical Alzheimer cognitive composite: measuring amyloid-related decline

1 reference

12 December 2020

Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial

1 reference

12 December 2020

Dietary and lifestyle guidelines for the prevention of Alzheimer's disease

1 reference

12 December 2020

Combining select neuropsychological assessment with blood-based biomarkers to detect mild Alzheimer's disease: a molecular neuropsychology approach.

1 reference

12 December 2020

Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis

1 reference

12 December 2020

Plasma proteins predict conversion to dementia from prodromal disease

1 reference

12 December 2020

Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues

1 reference

12 December 2020

Potential for primary prevention of Alzheimer's disease: an analysis of population-based data

1 reference

12 December 2020

Characteristics of the default mode functional connectivity in normal ageing and Alzheimer's disease using resting state fMRI with a combined approach of entropy-based and graph theoretical measurements

1 reference

12 December 2020

Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.

1 reference

12 December 2020

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

1 reference

12 December 2020

Public perceptions of presymptomatic testing for Alzheimer disease

1 reference

12 December 2020

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study

1 reference

12 December 2020

Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis

1 reference

12 December 2020

Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.

1 reference

12 December 2020

Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease.

1 reference

12 December 2020

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

1 reference

12 December 2020

Physical activity attenuates age-related biomarker alterations in preclinical AD

1 reference

12 December 2020

1 reference

12 December 2020

The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.

1 reference

12 December 2020

Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy

1 reference

12 December 2020

Subjective Cognitive Complaints in Parkinson Disease Without Dementia: A Preliminary Study.

1 reference

12 December 2020

Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies

1 reference

12 December 2020

Convergent genetic and expression data implicate immunity in Alzheimer's disease

1 reference

12 December 2020

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

1 reference

12 December 2020

APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.

1 reference

12 December 2020

Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageing.

1 reference

12 December 2020

Spreading of pathology in neurodegenerative diseases: a focus on human studies

1 reference

12 December 2020

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly

1 reference

12 December 2020

Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study

1 reference

12 December 2020

Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

1 reference

12 December 2020

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer's disease: an emerging method based upon brain dynamics

1 reference

12 December 2020

Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.

1 reference

12 December 2020

PART is part of Alzheimer disease

1 reference

12 December 2020

Brain neural synchronization and functional coupling in Alzheimer's disease as revealed by resting state EEG rhythms.

1 reference

12 December 2020

Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease.

1 reference

12 December 2020

Psychomotor retardation in elderly untreated depressed patients

1 reference

12 December 2020

Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network

1 reference

12 December 2020

Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument

1 reference

12 December 2020

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.

1 reference

12 December 2020

Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span

1 reference

12 December 2020

CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study.

1 reference

12 December 2020

Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum

1 reference

12 December 2020

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.

1 reference

12 December 2020

Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation

1 reference

12 December 2020

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

1 reference

12 December 2020

[(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology.

1 reference

12 December 2020

Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes

1 reference

12 December 2020

Declining functional connectivity and changing hub locations in Alzheimer's disease: an EEG study

1 reference

12 December 2020

Biomarkers in Sporadic and Familial Alzheimer's Disease

1 reference

12 December 2020

Tau positron emission tomographic imaging in aging and early Alzheimer disease

1 reference

12 December 2020

Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid

1 reference

12 December 2020

Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project

1 reference

12 December 2020

Dementia: The rising global tide of cognitive impairment

1 reference

12 December 2020

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

1 reference

12 December 2020

Diagnosis of Alzheimer's disease

1 reference

12 December 2020

Screening for dementia by memory testing

1 reference

12 December 2020

A safety test for Eastern equine encephalomyelitis vaccine

1 reference

12 December 2020

Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease.

1 reference

12 December 2020

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

12 December 2020

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

12 December 2020

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

1 reference

12 December 2020

Beta A4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians

1 reference

12 December 2020

Alterations in tau protein metabolism during normal aging.

1 reference

12 December 2020

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

12 December 2020

Frequency of stages of Alzheimer-related lesions in different age categories

1 reference

12 December 2020

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

1 reference

12 December 2020

Evaluation and use of diagnostic tests in Alzheimer's disease

1 reference

12 December 2020

Ethical guidelines of the Alzheimer Society of Canada.

1 reference

12 December 2020

Side-effects of rinsing fluids on the rat femoral artery. A histological and electron microscopic study.

1 reference

12 December 2020

10.1016/J.JALZ.2016.02.002

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012484%20AND%20SRC:MED&resulttype=core&format=json